Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
35 results about "DIAGNOSTIC STANDARD" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Ultrasonic measurement analytical system for compact bone substance density
ActiveCN101401732APromote disseminationHigh measurement accuracyOrgan movement/changes detectionUltrasonic/sonic/infrasonic dianostic techniquesBone densityHuman–machine interface
The invention discloses an ultrasound bone density measuring and analyzing system. The system comprises an ultrasound parameter measuring apparatus, a communication interface and a human machine interaction device, wherein the ultrasound parameter measuring apparatus comprises transmitting unit consisting of a pulse generator, a high-voltage pulse excitation module and a transmitting probe, an ultrasound receiving unit consisting of a receiving probe, a simulation pretreatment module, a gain adjustable amplifier, a phrase comparator, a high-speed ADC and an asynchronous FIFO, and a central processor, a power supply control module and a structural body. the human machine interaction device controls the ultrasound parameter measuring apparatus through the communication interface to measure the width of a calcaneus of a detected person, the transmission speed of an ultrasound wave in the calcaneus, broadband ultrasonic attenuation to calculate the bone intensity indexes and the bone density, so a medical report can be made according to diagnostic standards of osteoporosis and a special data base can be built for long term use. The system adopts wet or dry coupling and other technologies to improve the precision and accuracy of measure and has the advantages of easy carrying, low cost, no damage caused by radiation and can be use in long term monitoring of bone condition of the detected person.
Owner:HEFEI INSTITUTES OF PHYSICAL SCIENCE - CHINESE ACAD OF SCI
Configurable method and device for diagnostic protocol stack system based on CAN (controller area network) bus
ActiveCN103529821AAvoid duplication of developmentTroubleshoot porting issuesElectric testing/monitoringAbstraction layerArea network
The invention discloses a configurable method for a diagnostic protocol stack based on a CAN (controller area network) bus. The diagnostic protocol stack is realized according to international diagnostic standards ISO (international standardization organization) 15765 and AUTOSAR (automotive open system architecture) standards, and comprises an encapsulated network layer, an application layer module, an application layer standard interface, an ECU (electronic control unit) abstraction layer standard interface and a configurable file. When users carry out diagnostic requirement development, the existing module is applied for setting the configurable parameters through the configurable file, and only the concentration on the realization of application layer and bottom layer driving according to the standard interface is needed. The configurable method has the advantages that the universality, the reliability and the portability of diagnostic software are enhanced, the transplantation on different hardware platforms is convenient, the repeated development of the protocol stack of the network layer and an application layer is avoided, the development time is greatly shortened, the development cost is reduced, and the development and the expansion are convenient.
Owner:CHONGQING UNIV OF POSTS & TELECOMM
Automobile electronic control unit diagnostic function test method and system
ActiveCN103439961ASave time at workIncrease profitElectric testing/monitoringFunctional testingE communication
The invention discloses an automobile electronic control unit diagnostic function test method and a corresponding system. The method comprises the steps of sending fault request data representing bus fault generation to an electronic control unit, enabling the electronic control unit to generate corresponding communication fault codes after receiving the fault request data, reading the communication fault codes, verifying whether the communication fault codes are right according to the fault request data and the automobile electronic control unit diagnostic standard, sending fault clearing request data representing clearing of faults to the electronic control unit, enabling the electronic control unit to clear the communication fault codes after receiving the fault clearing request data, and verifying whether the communication fault codes exist in the electronic control unit.
Owner:ZHEJIANG GEELY AUTOMOBILE RES INST CO LTD +1
Application of biomarker for preparing medicine for predicting feedback response of 5-aminosalicylic acid in treatment of ulcerative colitis
The invention discloses application of a biomarker for preparing a medicine for predicting feedback response of 5-aminosalicylic acid in treatment of ulcerative colitis. The biomarker determined in the invention is the basis of a target biomarker associated with gender difference response when 5-aminosalicylic acid (5-ASA) is used to treat ulcerative colitis (UC). The biomarker comprises a group of protein biomarkers which can differentiate response difference for treatment by 5-ASA between different genders and determine the curative effect by using 5-ASA under different UC conditions. Meanwhile, a novel drug target for a UC novel curative method is effectively determined and verified by using the biomarker with specificity for genders and disease focus parts, novel diagnostic reagents, medicines, methods and diagnostic standards are developed, and the application is used for establishing a UC treatment policy.
Owner:HAYAO CIHANG PHARM CO LTD +1
In-hospital infection early warning construction method based on hospital information system
InactiveCN109065178ARealize automatic extractionAvoid infectionEpidemiological alert systemsNatural language data processingMedical recordData information
The invention discloses an in-hospital infection early warning construction method based on a hospital information system. According to hospital infection diagnosis standards, firstly, structured dataand unstructured data required for infection are collected and sorted; secondly, word segmentation and part-of-speech tagging of the unstructured data are performed to obtain a medical record document set after word segmentation; thirdly, the unstructured data after word segmentation and part-of-speech tagging is subjected to natural language processing; fourthly, the information is extracted through annotation rules of regular expressions and the machine learning technology to obtain the target data information; and lastly, the target data information and the structured data are constructedinto an in-hospital infection early warning data system. The method is advantaged in that the in-hospital infection early warning system including the structured data and the unstructured data is constructed in the hospital information system in the prior art, doctors can be assisted in in-hospital infection diagnosis, and the staff of the hospital-acquired infection control department is facilitated to check suspected medical records in time and confirm or eliminate them in the system.
Owner:THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIV
Controller area network decoder (can-d)
PendingUS20210178996A1Registering/indicating working of vehiclesMachine learningData packArea network
A system and method for decoding an unknown automotive controller area network (“CAN”) message definitions. CAN data vehicle signal mappings are typically held in secret and varied by automotive model and year. Without knowledge of the mappings, the wealth of real-time vehicle data hidden in the automotive CAN packets is uninterpretable—impeding research, after-market tuning, efficiency and performance monitoring, fault diagnosis, and privacy-related technologies. This technology can ascertain the CAN signals' boundaries (start bit and length), endianness (byte ordering), signedness (binary-to-integer encoding) from raw CAN data. This allows conversion of CAN data to time series. Interpreting the translated CAN data's physical meaning and finding a linear mapping to standard units (e.g., knowing the signal is speed and scaling values to represent units of miles per hour) can be achieved for many signals by leveraging diagnostic standards to obtain real-time measurements of in-vehicle systems. The system and method can be integrated into lightweight hardware enabling an OBD-II plugin for real-time in-vehicle CAN decoding or run on standard computers. The system can output a standard DBC file with the signal definition information.
Owner:UT BATTELLE LLC
Method and system for testing and guiding female menstrual cycle in multiple environments
PendingCN108938011AConvenient self-testConvenient adjustment guide methodSurgeryVaccination/ovulation diagnosticsFemale groupObstetrics
The invention provides a method for testing and guiding a female menstrual cycle in multiple environments. The method comprises the steps that the female menstrual cycle conditions in different environments are collected, the female menstrual cycle conditions are tested and evaluated to provide corresponding guidance and regulate the female menstrual cycle when the female menstrual cycle is disordered so as to ensure the female physical and psychological health and work capacity, women do not need to consume time and labor to perform clinical examination and evaluation, the method is convenient and fast, the clinical diagnostic standard is adopted, the accuracy degree is high, the method can adapt to the examination and evaluation of the menstrual cycle of large-scale female groups, and the group guidance is made.
Owner:INST OF ENVIRONMENTAL MEDICINE & OCCUPATIONAL MEDICINE ACAD OF MILITARY MEDICINE ACAD OF MILITARY SCI
Application of biomarkers in the preparation of drugs for predicting the feedback response of 5-aminosalicylic acid in the treatment of ulcerative colitis
ActiveCN103149371BReduce 5-ASA side effectsReduce the likelihood of treatmentBiological testingUlcerative colitisSalicylic acid
Owner:HAYAO CIHANG PHARM CO LTD +1
Diagnostic marker of inferior myocardial infarction and/or anterior myocardial infarction
InactiveCN108680692AAvoid irreversible changesAvoid damageComponent separationDisease diagnosisNormal peopleInferior Myocardial Infarction
The invention discloses a diagnostic marker of inferior myocardial infarction and / or anterior myocardial infarction. The diagnostic standard substance is a lysophosphatidylcholine substance; a high performance liquid chromatography-mass spectrometry detects that the contents of lysoPC (14:0), lysoPC (15:0), lysoPC (17:0) and lysoPC (18:0) in blood of patients suffering from the myocardial infarction are obviously lower than those in blood of normal people, and the contents of the lysoPC (14:0), the lysoPC (15:0), the lysoPC (17:0) and the lysoPC (18:0) in blood of patients suffering from the inferior myocardial infarction and the anterior myocardial infarction also have significant differences. According to research results, the invention develops a product for diagnosing the myocardial infarction, and the diagnostic product has high sensitivity and strong specificity and can be used in clinical popularization.
Owner:TIANJIN CITY THIRD CENT HOSPITAL
Methods and systems for diagnostic standard establishment and intelligent diagnosis of wind generation set oil monitoring
InactiveCN104731955AImprove accuracyPlay an early warning roleMaterial testing goodsOther databases queryingElectricityNormal values
The invention discloses methods and systems for diagnostic standard establishment and intelligent diagnosis of wind generation set oil monitoring. The method for diagnostic standard establishment comprises the steps that normality testing is carried out on oil test data, a calculating method for diagnostic standards is selected on the basis of results of normality testing, and the diagnostic standards are obtained through calculation. The method for intelligent diagnosis of wind generation set oil monitoring comprises the steps of establishing a diagnostic standard library according to the standard establishment method, extracting the diagnostic standards from the diagnostic standard library according to monitoring objects, and comparing the oil test data with the extracted diagnostic standards to judge whether the current oil test data belong to normal values, or attention values or alarming values. By means of the method and system for diagnostic standard establishment, accurate and objective diagnostic standards can be established, pertinence is high, accuracy is high, and an effective early-warning effect can be achieved; the method and system for intelligent diagnosis of wind generation set oil monitoring can greatly improve oil monitoring analytical judgment efficiency.
Owner:LONGYUAN BEIJING WIND POWER ENG TECH
Method for establishing mycobacterium abscessus RUO database and subtype super map
ActiveCN106483188AImprove identification efficiencyMaterial analysis by electric/magnetic meansPhylogenetic treeFlight time
The invention discloses a method for establishing a mycobacterium abscessus RUO database and a subtype super map. The method is characterized by including the following steps of mycobacterium abscessus strain collecting and DNA extracting; 2, gene library preparing and illumine HiSeq sequencing; 3, genome establishing and phylogenetic tree establishing; 4, sample preparing and strain detecting; 5, accuracy confirming. According to the method, mycobacterium abscessus subspecies are analyzed and determined; ionization-flight-time mass-spectrometric-detection subspecies information is desorbed in the mode that a matrix assists in laser, the RUO database and the established super map are established, the sensitivity and the specificity are detected through strain blind testing, the operation procedure and the diagnostic standard for subspecies-level laboratory identification are formulated, a work chain of the microbial standard in-vitro-diagnosis procedure is added, and the efficiency of all microbiological labs on mycobacterium abscessus subtype identification is improved.
Owner:SHANGHAI PULMONARY HOSPITAL
Placental implantation prediction method based on hidden Markov model
InactiveCN104392145AThe result is accurateSpecial data processing applicationsPredictive methodsHide markov model
The invention relates to a placental implantation prediction method based on a hidden Markov model. The method comprises the following steps: firstly, extracting lying-in woman data, namely obtaining x lying-in woman data from a hospital or a health organization, wherein the observation objects of the lying-in woman data include history of cesarean section, placenta previa, age of the lying-in woman, history of fecundity and placenta position, and x is 200; secondly, building initial data of the hidden Markov model; thirdly, predicting the placental implantation type of a case on the basis of the initial data of the hidden Markov model. According to the method, the limitations and deficiencies of heat effect, easy fetal movement interference, no unified diagnostic standards, high expense and the like of existing MRI (magnetic resonance imaging) diagnosis are made up for, the prediction of the placental implantation type is relatively accurate, and great contribution is made for guaranteeing lives of lying-in women and fetuses.
Owner:FUZHOU UNIV
Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
ActiveUS20170261492A1Good effectFaster and effective disease controlOrganic active ingredientsDisease diagnosisMedicineNon responders
A process and system directed to a more effective, individual based treatment regimen which is built on clinical identified target biomarkers associated with gender differential responses to mesalamine, and includes one or more panels of target biomarkers that distinguishes mesalamine response differences between genders and determines the efficacy of mesalamine for patients being treated for various UC conditions and effectively identifies and validates novel drug targets for new UC therapeutics, new diagnostics and diagnostics standards for UC therapeutic strategies.
Owner:MUSIDORA BIOTECH LLC
Cellular pathology image quality evaluation method
PendingCN114820510AIncrease workloadSolve the workloadImage enhancementImage analysisImaging qualitySample image
The invention discloses a cell pathology image quality evaluation method, and relates to the problem of lack of a cell pathology image quality evaluation method in an automatic pathology diagnosis technology. The pathological section digitalization accumulates a large amount of data, which is an important premise of automatic pathological diagnosis. However, unqualified cell pathological images generated by scanning severely affect the efficiency of automatic pathological diagnosis, and even cause misdiagnosis and missed diagnosis. Many existing image quality evaluation methods do not consider evaluation standards of cell pathology doctors on sample images and are not suitable for the field of automatic pathological diagnosis. In order to solve the problem, the invention provides a cell pathology image quality evaluation method based on the Chinese expert consensus of digital pathology image acquisition and image quality control of cervical liquid-based cytology and the TBS (Theoresda system) diagnostic standard. Experiments show that the method can effectively evaluate the quality of the cell pathological image and improve the efficiency of automatic pathological diagnosis. The method is applied to quality evaluation of cell pathology images.
Owner:HARBIN UNIV OF SCI & TECH
Acquisition method of acquisition device capable of synchronously acquiring multiple dynamic data
PendingCN111513761ARealize evaluationCheck impactStethoscopeHeart/pulse rate measurement devicesMedical equipmentHeart disease
The invention discloses an acquisition method of an acquisition device capable of synchronously acquiring multiple dynamic data, and belongs to the technical field of medical equipment. According to the acquisition method of the acquisition device capable of synchronously acquiring multiple dynamic data, ultrasonic cardiogram and electrocardiogram data of a tested person are synchronously acquiredthrough an ultrasonic probe and an ECG patch of ultrasonic equipment, meanwhile, a digital stethoscope is directly connected to a synchronous data acquisition device in a wired mode, a wav audio dataformat is transmitted, a newborn born in a trial hospital is used as a research object, cardiac ultrasonography is used as a diagnostic standard of congenital heart disease, the newborn is divided into two screening groups for research, artificial heart sound auscultation, heart sound digital auscultation, ECG examination, cardiac ultrasonography and percutaneous blood oxygen saturation measurement are carried out to determine the type and severity of the congenital heart disease, ultrasonic cardiogram, electrocardiogram and cardiophonogram data can be synchronously acquired through the self-made synchronous acquisition device, and comprehensive evaluation of dynamic heart monitoring is achieved.
Owner:ZHEJIANG UNIV +1
Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
ActiveUS10295527B2Good effectFaster and effective disease controlOrganic active ingredientsDisease diagnosisMedicineNon responders
Owner:MUSIDORA BIOTECH LLC
Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment
PendingUS20190376948A1Reduce riskDelay progressOrganic active ingredientsDisease diagnosisInflammatory bowel diseaseCvd risk
A process and system directed to a more effective, individual based treatment regimen which is built on clinical identified predictive target biomarkers associated with predicting the risk of an individual developing IBD and includes one or more predictive panels of prediction target biomarkers that are used to determine the risk of an individual developing IBD for determining if a therapy should be administered to reduce the risk and further determines the efficacy of treating the individual with mesalamine and effectively identifies and validates novel drug targets for new IBD therapeutics, new diagnostics and diagnostics standards for IBD therapeutic strategies.
Owner:MUSIDORA BIOTECH LLC
Application of cd4+t lymphocyte characteristic protein in identifying latent tuberculosis infection and active pulmonary tuberculosis
The invention discloses application of CD4+T lymphocyte characteristic protein to identification of active tuberculosis and latent tuberculosis infection (LTBI). The invention provides application ofa substance for detecting an expression quantity of integrin beta-3 and / or integrin-linked kinase to preparation of a product for distinguishing or identifying or assisting to distinguish or identifya patient with the active tuberculosis and a latent tuberculosis infection infected person. The invention finds out that integrin beta-3 and integrin-linked kinase protein can distinguish an LTBI patient and an initially-treated active tuberculosis patient, and novel diagnostic standards are provided for diagnosing the LTBI patient and the initially-treated active tuberculosis patient.
Owner:BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
Application of CD4+T lymphocyte characteristic protein to identification of latent tuberculosis infection and active tuberculosis
The invention discloses application of CD4+T lymphocyte characteristic protein to identification of active tuberculosis and latent tuberculosis infection (LTBI). The invention provides application ofa substance for detecting an expression quantity of integrin beta-3 and / or integrin-linked kinase to preparation of a product for distinguishing or identifying or assisting to distinguish or identifya patient with the active tuberculosis and a latent tuberculosis infection infected person. The invention finds out that integrin beta-3 and integrin-linked kinase protein can distinguish an LTBI patient and an initially-treated active tuberculosis patient, and novel diagnostic standards are provided for diagnosing the LTBI patient and the initially-treated active tuberculosis patient.
Owner:BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
Application of joint synovial fluid biomarker ADAMDEC1
The invention discloses a joint synovial fluid biomarker ADAMDEC1 and an application of a detection product of the joint synovial fluid biomarker ADAMDEC1 in diagnosis and differentiation of two diseases including rheumatoid arthritis and osteoarthritis. The biomarker ADAMDEC1 has a very high diagnostic value in the aspect of diagnosing and distinguishing rheumatoid arthritis and osteoarthritis, is high in diagnostic accuracy, more directly aims at local focuses compared with an existing diagnostic standard, and is easy to operate.
Owner:东阳市人民医院
A vehicle diagnosis method, diagnosis terminal and diagnosis box
ActiveCN108958224BAvoid frequent switchingImprove diagnostic efficiencyElectric testing/monitoringDiagnostic modalitiesDiagnosis standards
An embodiment of the present application provides a vehicle diagnosis method, a diagnosis terminal and a diagnosis box, wherein a vehicle diagnosis method includes: the diagnosis terminal determines the diagnosis category of the vehicle to be diagnosed according to the received diagnosis instruction; further, according to the diagnosis category Determine the target diagnostic mode of the diagnostic box required for diagnosing the vehicle to be diagnosed; the diagnostic terminal obtains the current diagnostic mode of the diagnostic box; if the two diagnostic modes are different, the diagnostic terminal sends a diagnostic mode switching command to the diagnostic box To prompt the diagnostic box to switch to the target diagnostic mode, so that the diagnostic terminal can diagnose the vehicle to be diagnosed through the diagnostic box working in the target diagnostic mode. By adopting the embodiment of the present application, by integrating the diagnostic box and the diagnostic software that support the diagnostic standards of the new model and the old model, the automatic selection of the appropriate diagnostic mode according to the model to be diagnosed is realized, and the frequent switching of the diagnosis of the diagnostic box is avoided. Mode and diagnostic software, improving diagnostic efficiency.
Owner:LAUNCH TECH CO LTD
Viral pneumonia auxiliary diagnosis device and method
The invention relates to the technical field of medical diagnosis, in particular to a viral pneumonia auxiliary diagnosis device and method.The viral pneumonia auxiliary diagnosis device comprises a cloud server and an information collection unit, the information collection unit comprises a face recognition module and an identity card recognition module, and auxiliary judgment software is installed in the cloud server; and the auxiliary judgment software comprises an image processing module, an auxiliary analysis module and a file creation module. According to the invention, the problem that no special equipment for unified management and further analysis of data related to the diagnostic standard exists at present, and auxiliary diagnosis suggestions cannot be provided for related departments and departments can be solved.
Owner:杨昆
Rhizoma cimicifugae hemorrhoid breaking decoction
The invention discloses a rhizoma cimicifugae hemorrhoid breaking decoction. The rhizoma cimicifugae hemorrhoid breaking decoction is a fixed traditional Chinese medicine prescription. The rhizoma cimicifugae hemorrhoid breaking decoction is characterized by being prepared from the following raw medicinal materials in parts by weight: 10-30 parts of rhizoma cimicifugae, 5-15 parts of radix angelicae, 5-15 parts of radix ligustici sinensis, 5-15 parts of raw rhizoma atractylodis macrocephalae, 5-15 parts of raw rhizoma alismatis and 5-15 parts of vinegar rhizoma sparganii. Diagnostic standards and curative effect standards of 'guide for clinical diagnosis and treatment of hemorrhoids' (2006) (hereinafter referred to as 'guide') are executed; the causes of haemorrhoids are analyzed by using a new theory of traditional Chinese medicine, and a treatment rule and a prescription are determined; and the empirical evidence shows that the rhizoma cimicifugae hemorrhoid breaking decoction can avoid postoperative pain and sequelae risks of a patient caused by operative treatment, widens the symptom type range of hemorrhoids treated by oral medicine, accelerates the healing speed of the hemorrhoids, reduces the recurrence probability of the hemorrhoids, and also saves the cost at the same time.
Owner:青岛王晨龙中医研究所
A configurable method and device for a CAN bus-based diagnostic protocol stack system
ActiveCN103529821BAvoid duplication of developmentTroubleshoot porting issuesElectric testing/monitoringAbstraction layerArea network
Owner:CHONGQING UNIV OF POSTS & TELECOMM
Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis
ActiveUS20190242872A1Good effectFaster and effective disease controlOrganic active ingredientsDisease diagnosisMedicineNon responders
Owner:MUSIDORA BIOTECH LLC
Establishment of zebra fish osteoporosis diagnostic standard
PendingCN114842966AFast imagingEasy to operateMedical simulationClimate change adaptationBone densityPhysiology
The invention discloses an establishment method of zebra fish osteoporosis diagnosis standards and a zebra fish osteoporosis diagnosis system. The method comprises the following steps: constructing a zebra fish osteoporosis model, scanning a zebra fish skull and / or spine by using Micro-CT, counting values of zebra fish bone density and bone volume percentage, calculating Mean + / -SD, calculating a T value through a Mean value and an SD value, judging, and further considering a bone mass loss value of a scanned part according to the bone density and / or bone volume percentage, so as to determine the osteoporosis of the zebra fish. The zebra fish osteoporosis diagnosis standard is obtained. The zebra fish osteoporosis diagnostic standard constructed by the invention can be directly used for evaluating medicines, and provides support for subsequent judgment of the degree of relieving bone loss by medicines. Diagnostic data support is provided for establishment of a zebrafish osteoporosis model, development of osteoporosis drugs and the like.
Owner:SUN YAT SEN UNIV
Molding diagnosis device
Provided is a molding diagnosis device for continuously diagnosing the operational stability of a molding machine detected during continuous automatic operation and reporting necessary messages to the operator by displaying same on a display device. In addition to setting nozzle temperature as a diagnostic category for operational stability of the molding machine body (10) in a storage unit (4), a standard value for the deviation in nozzle temperature is stored as a diagnostic standard value. When an assessment unit (5) determines that the deviation between the maximum value and the minimum value for the nozzle temperature sampled over the number of shots set by the shot number-setting unit (60) is at or above the standard value for the nozzle temperature deviation set in the storage unit (4), character data that "there is variation in the nozzle temperature," which indicates that the deviation in nozzle temperature is greater than the standard value, is displayed on a monitor unit (6).
Owner:TOYO MACH & METAL CO LTD
A kind of Helicobacter pylori staining liquid and staining method thereof
ActiveCN109916690BReduce workloadSlight negligible fadingPreparing sample for investigationXylyleneStaining
Owner:SHANGHAI BAOSHAN DISTRICT RENHE HOSPITAL
Real-time detection and quantitative evaluation device for female sexual functions
InactiveCN110236577ASimple structureEasy to useSensorsTelemetric patient monitoringMedical equipmentGynecology
The invention discloses a real-time detection and quantitative evaluation device for female sexual functions, and relates to medicine equipment. The device is used for solving the problems that an accurate quantitative diagnostic standard cannot be given out for the female sexual health in current clinical treatment, and the female sexual health cannot be accurately judged. The real-time detection and quantitative evaluation device for female sexual functions comprises a sleeve, sensors arranged on the surface of the sleeve body and processing equipment connected with the sensors; the sleeve body is used for being inserted into the genitals of the female; the sensors are used for collecting biological data of corresponding positions of the sleeve body; the processing equipment is used for acquiring the biological data and sending the biological data to an external terminal. The real-time detection and quantitative evaluation device for female sexual functions evaluates the female sexual health in a numeralized, standardized and accurately quantified manner by detecting the relevant data capable of being quantified in real time.
Owner:张振锋 +1
Method and device for conveniently and efficiently identifying cerebrospinal fluid in intraspinal anesthesia operation
ActiveCN113499039AWon't hurtIncrease luminous fluxCharacter and pattern recognitionSensorsFt ir spectraSaline
The invention relates to the technical field of medical treatment and public health, and provides a method and device for conveniently and efficiently identifying cerebrospinal fluid in intraspinal anesthesia operation, and the method comprises the following steps: 1, understanding the spectroscopy characteristics of cerebrospinal fluid, local anesthesia drugs and normal saline; 2, exploring ATR-FTIR spectral characteristic discrimination indexes of cerebrospinal fluid, local anesthesia drugs and normal saline, and establishing a diagnostic standard; 3, further expanding and constructing a characteristic atlas database; and 4, carrying out Fourier transform infrared spectroscopic analysis on a liquid sample obtained in the intraspinal anesthesia operation by adopting a handheld portable infrared spectrometer, obtaining a corresponding liquid sample atlas according to relative vibration and molecular rotation information among atoms in molecules of the liquid sample, and comparing the liquid sample atlas with the characteristic atlas database to obtain a comparison result, and judging whether the liquid sample is cerebrospinal fluid, local anesthesia medicine or normal saline according to the comparison result through an ATR-FTIR spectrum judgment standard.
Owner:PEKING UNIV THIRD HOSPITAL
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com